CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
In this study, researchers will learn more about a study drug called BIIB091 in participants with MS who may be experiencing relapses. It is...
Phase 2
San Antonio, Texas, United States and 76 other locations
(maintenance) in people with systemic lupus erythematosus (lupus), infantile spasms, adults with acute relapses or flares of multiple sclerosis...
Phase 2
San Antonio, Texas, United States and 2 other locations
This study will evaluate the impact of ofatumumab in Relapsing Remitting Multiple Sclerosis (RRMS) participants that are very early...
Phase 4
San Antonio, Texas, United States and 35 other locations
To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...
Phase 3
San Antonio, Texas, United States and 237 other locations
This is a Phase 3 extension, global, multicenter study to assess the long-term safety and tolerability of tolebrutinib in adult participants (aged ≥1...
Phase 3
San Antonio, Texas, United States and 314 other locations
) neo-antigen in subjects with relapsing multiple sclerosis (RMS).COVID-19 sub-study:The purpose of this research sub-study is to e...
Phase 3
San Antonio, Texas, United States and 297 other locations
Clinical trials
Research sites
Resources
Legal